Search

James G Shiah

from Irvine, CA
Get Report
Related to:
Emily Shiah, 28Eric Shiah, 29
Connected to:
Bruce L Shiah, 57John P Shiah, 89Armond R Shian, 57Christopher R Shian, 45Davy H Shian, 70Dawn L Shiang, 62Elizabeth Shiang, 60Lynn D Shiang, 73Paul J Shiang, 69Epharim R Shiao, 36

James Shiah Phones & Addresses

  • 16 Lucero W, Irvine, CA 92620 (949) 232-7797

Work

Company: Allergan Position: Senior scientist

Education

School / High School: University of Utah

Skills

Pharmaceutical Industry • Clinical Development • Drug Development • Clinical Trials • Gmp • Validation

Industries

Pharmaceuticals

Public records

Vehicle Records

James Shiah

View page
Address:
16 Lucero W, Irvine, CA 92620
VIN:
JN8AS58T49W056127
Make:
NISSAN
Model:
ROGUE
Year:
2009

Resumes

Resumes

James Shiah Photo 1

Senior Scientist

View page
Location:
Los Angeles, CA
Industry:
Pharmaceuticals
Work:
Allergan
Senior Scientist
Education:
University of Utah
Skills:
Pharmaceutical Industry
Clinical Development
Drug Development
Clinical Trials
Gmp
Validation

Publications

Us Patents

Bioerodible Polyester Polymer Implants And Related Methods Of Use

View page
US Patent:
20200375889, Dec 3, 2020
Filed:
May 29, 2020
Appl. No.:
16/888384
Inventors:
- San Clemente CA, US
James Shiah - San Clemente CA, US
Jack Xie - San Clemente CA, US
Jia-Ying Yang - San Clemente CA, US
International Classification:
A61K 9/00
A61K 31/4439
A61K 47/34
Abstract:
The present disclosure provides compositions that enable sustained release of a small molecule tyrosine kinase inhibitor, such as axitinib from a bioerodible polyester polymer implant for the treatment of disease. The composition is especially suitable for treating ophthalmic indications, such as neovascular age related macular degeneration and diabetic macular edema, by intravitreal injection of the implant. The implant is designed to be pre-loaded into a small diameter needle and injected via self-sealing scleral needle penetration at the pars plana. Small molecule tyrosine kinase inhibitors may be released from the implants over a period of one week to three years.

Extended Release Biodegradable Ocular Implants

View page
US Patent:
20190254964, Aug 22, 2019
Filed:
Dec 17, 2018
Appl. No.:
16/222886
Inventors:
- Irvine CA, US
James Jane-Guo Shiah - Irvine CA, US
Qing Lin - Fremont CA, US
International Classification:
A61K 9/00
A61K 31/573
A61K 47/34
A61K 31/57
Abstract:
Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Extended Release Biodegradable Ocular Implants

View page
US Patent:
20150209276, Jul 30, 2015
Filed:
Jan 30, 2015
Appl. No.:
14/610780
Inventors:
- Irvine CA, US
James Jane-Guo Shiah - Irvine CA, US
Qing Lin - Fremont CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 9/00
A61K 47/34
A61K 31/573
Abstract:
Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.
Control profile
James G Shiah from Irvine, CA Get Report